Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT06527846
Post Marketing Surveillance of JARDIANCE in Chronic Kidney Disease
Sponsor: Boehringer Ingelheim
View on ClinicalTrials.gov
Summary
Study objective is to investigate the safety and effectiveness of long-term daily use of JARDIANCE® Tablets in patients with chronic kidney disease under real-world use.
Official title: Post Marketing Surveillance on Long Term Use of JARDIANCE® Tablets in Patients With Chronic Kidney Disease in Japan
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
1024
Start Date
2024-10-22
Completion Date
2027-03-31
Last Updated
2026-03-19
Healthy Volunteers
No
Conditions
Interventions
DRUG
JARDIANCE®
JARDIANCE®
Locations (1)
Nippon Boehringer Ingelheim Co., Ltd.
Tokyo, Japan